5 | Neurotransmitter Agents (Neurotransmitter)IBA
10/2019
-
08/2002 |
4 | Adenosine (Adenocard)FDA LinkGeneric
10/2019
-
12/2008 |
4 | Caffeine (No Doz)FDA LinkGeneric
04/2015
-
01/2012 |
4 | Insulin (Novolin)FDA Link
10/2014
-
01/2012 |
4 | CatecholaminesIBA
04/2012
-
11/2006 |
3 | SmokeIBA
01/2014
-
12/2011 |
3 | Oxygen (Dioxygen)IBA
12/2012
-
08/2002 |
2 | Purinergic P1 Receptors (Adenosine Receptor)IBA
04/2015
-
12/2012 |
2 | LipidsIBA
10/2014
-
12/2013 |
2 | Dopamine (Intropin)FDA LinkGeneric
12/2012
-
01/2012 |
2 | Glutathione (Reduced Glutathione)IBA
01/2012
-
03/2004 |
1 | Purinergic P2 Receptors (ADP Receptor)IBA
10/2019 |
1 | Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2019 |
1 | NestinIBA
10/2019 |
1 | Adenosine Triphosphate (ATP)IBA
10/2019 |
1 | AminesIBA
04/2015 |
1 | 5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
04/2015 |
1 | SodiumIBA
04/2015 |
1 | N- (4- cyanophenyl)- 2- (4- (2,3,6,7- tetrahydro- 2,6- dioxo- 1,3- dipropyl- 1H- purin- 8- yl)- phenoxy)acetamideIBA
04/2015 |
1 | XanthineIBA
04/2015 |
1 | 1,3-dipropyl-8-cyclopentylxanthineIBA
04/2015 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2015 |
1 | LeptinIBA
10/2014 |
1 | Glucose (Dextrose)FDA LinkGeneric
10/2014 |
1 | CholesterolIBA
10/2014 |
1 | Triglycerides (Triacylglycerol)IBA
10/2014 |
1 | Blood Proteins (Serum Proteins)IBA
01/2014 |
1 | GasesIBA
01/2014 |
1 | Biomarkers (Surrogate Marker)IBA
01/2014 |
1 | CytokinesIBA
01/2014 |
1 | ElementsIBA
12/2013 |
1 | Nifedipine (Adalat)FDA LinkGeneric
04/2012 |
1 | PlasticsIBA
01/2012 |
1 | S(8)IBA
01/2012 |
1 | antineoplaston A10 (A 10)IBA
01/2012 |
1 | erythromycin propionate-N-acetylcysteinateIBA
01/2012 |
1 | Carvedilol (Coreg)FDA LinkGeneric
01/2012 |
1 | Cyclic AMP (AMP, Cyclic)IBA
01/2012 |
1 | Nonesterified Fatty Acids (NEFA)IBA
01/2012 |
1 | Adrenergic Receptors (Adrenergic Receptor)IBA
01/2012 |
1 | Serotonin (5 Hydroxytryptamine)IBA
01/2012 |
1 | Sucrose (Saccharose)IBA
01/2012 |
1 | NADPH Oxidases (NAD(P)H oxidase)IBA
10/2011 |
1 | 4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
10/2011 |
1 | RotenoneIBA
10/2011 |
1 | Caveolin 1IBA
10/2011 |
1 | CeramidesIBA
10/2011 |
1 | acetovanillone (apocynin)IBA
10/2011 |
1 | dihydroethidiumIBA
10/2011 |
1 | Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
10/2011 |
1 | Tetraethylammonium (Tetraethylammonium Bromide)IBA
09/2009 |
1 | CalciumIBA
09/2009 |
1 | AcidsIBA
09/2009 |
1 | iberiotoxinIBA
09/2009 |
1 | Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
09/2009 |
1 | Adenylyl Cyclases (Adenylyl Cyclase)IBA
08/2009 |
1 | IonomycinIBA
08/2009 |
1 | 9-(tetrahydro-2-furyl)-adenineIBA
08/2009 |
1 | Dopamine Agonists (Dopamine Agonist)IBA
12/2008 |
1 | Protein Isoforms (Isoforms)IBA
07/2007 |
1 | ErythropoietinFDA Link
08/2002 |